Image Gallery

  • Table 1: Primary, Secondary and Other Endpoints in Patients with Cardiovascular Disease Receiving Evolocumab and Patients Receiving Placebo
  • Figure 1: Potential Links Between Pregnancy Complications and Future Cardiovascular Health in Mother and Child
  • Table 3: Recommended Timing of Discontinuation of Direct Oral Anticoagulants Pre-procedure
  • Table 2: Effect of Direct Oral Anticoagulants on Haemostasis Tests and Drug Concentration Quantification
  • Table 1: Drug Interactions with Direct Oral Anticoagulants
  • Table 4: Selected online materials available for AF education, and their readability levels, as assessed by the FKGL and SMOG measures
  • Table 3: Readability and Grade Level of Selected Instruments for Patient-Reported Health Status Instrument
  • Figure 1: Addressing Atrial Fibrillation (AF) and Health Literacy
  • Table 2: AHRQ Health Literacy Universal Precautions Toolkit Components and Modification for Atrial Fibrillation (AF) Clinical Care and Practice
  • Table 1: Future Directions for Incorporating Health Literacy in Atrial Fibrillation (AF) Clinical Investigation and Epidemiology
  • Figure 1: Cardiac Magnetic Resonance Exam of a 70-yearold Female Patient with Takotsubo Cardiomyopathy
  • Table 2: Clinical Usefulness of Cardiac Magnetic Resonance in Patients with Suspected Takotsubo Syndrome